Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 7—July 2003

Antimicrobial Susceptibility Breakpoints and First-Step parC Mutations in Streptococcus pneumoniae: Redefining Fluoroquinolone Resistance

Sue Lim*†, Darrin Bast*†, Allison McGeer*†, Joyce de Azavedo*†, and Donald E. Low*†Comments to Author 
Author affiliations: *Toronto Medical Laboratories/Mount Sinai Hospital, Toronto, Ontario, Canada; †University of Toronto, Toronto, Ontario, Canada

Main Article

Table 3

The prevalence of ParC amino acid substitutions among all strains according to their levofloxacin and ciprofloxacin MICs

MIC (μg/mL) No. strains with ParC amino acid substitution at 79 or 83
Ciprofloxacin (%) Levofloxacin (%)
2 4/14 (29) 48/82 (59)
4 24/37 (65) 5/8 (63)
8 11/12 (92) 10/10 (100)
>8 22/22 (100) 15/15 (100)
Total 62/87 (71) 78/115 (69)

Main Article

Page created: December 22, 2010
Page updated: December 22, 2010
Page reviewed: December 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.